Sanofi SA logo

Sanofi SA (SNW1)

Market Closed
15 Oct, 08:00 PM
XFRA XFRA
€
5. 60
+0.2
+3.7037%
€
42.1B Market Cap
- P/E Ratio
0.33% Div Yield
0 Volume
0 Eps
€ 5.4
Previous Close
Add Transaction
Day Range
5.4 5.6
Year Range
5.4 12.89
Want to track SNW1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SNW1 closed today higher at €5.6, an increase of 3.7037% from yesterday's close, completing a monthly decrease of -5.0847% or -€0.3. Over the past 12 months, SNW1 stock lost -56.542%.
SNW1 pays dividends to its shareholders, with the most recent payment made on May 13, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

SNW1 Chart

People also search for

Amgen Inc. Canadian Depositary Receipt
€ 18.9
0%
Gilead Sciences Inc. Canadian Depositary Receipt
€ 19.1
+3.2432%
Abbott Laboratories CDR
€ 11.2
0%
Novo Nordisk A/S
€ 10.2
+3.0303%
Pfizer Inc.
€ 7
+6.0606%

Sanofi SA (SNW1) FAQ

What is the stock price today?

The current price is €5.60.

On which exchange is it traded?

Sanofi SA is listed on XFRA.

What is its stock symbol?

The ticker symbol is SNW1.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.33%.

What is its market cap?

As of today, the market cap is 42.1B.

Has Sanofi SA ever had a stock split?

No, there has never been a stock split.

Sanofi SA Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Adam Buchajski CEO
XFRA Exchange
- ISIN
Poland Country
88 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Sanofi SA is a prominent French multinational pharmaceutical and healthcare company based in Paris, recognized for its dedication to the research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, the company has grown significantly through pivotal mergers, including those with Synthélabo in 1999 and Aventis in 2004, creating a global entity with a workforce exceeding 90,000 employees across 90 countries. Sanofi strategically focuses on seven major therapeutic areas: cardiovascular health, central nervous system disorders, diabetes care, internal medicine, oncology, thrombosis prevention, and vaccine development. Notably, it stands as the world's largest producer of vaccines through its subsidiary, Sanofi Pasteur, reinforcing its commitment to public health. The company maintains a strong emphasis on research and development, utilizing AI-driven methodologies to focus on immunology, neurology, diabetes innovation, and mRNA technologies, while managing a robust pipeline of 80 compounds in clinical development aimed at addressing unmet medical needs worldwide.

Products and Services

  • Prescription Drugs

    Sanofi’s portfolio includes leading prescription medications such as Dupixent, which is utilized for treating eczema and various autoimmune conditions, demonstrating significant advancements in dermatological and immunological therapies.

  • Lovenox

    This medication is essential for thrombosis management, serving as an anticoagulant that prevents and treats blood clots, playing a crucial role in patient care for at-risk populations.

  • Taxotere

    Used in cancer treatment, Taxotere is an important chemotherapy agent that assists in managing various cancer types, contributing to the broader oncology therapeutic landscape.

  • Treatments for Rare Diseases

    Sanofi provides specialized treatments for rare conditions, such as Gaucher's disease and hemophilia, reflecting its commitment to addressing the needs of patients with unique medical challenges.

  • Over-the-Counter Products

    The company also markets a range of over-the-counter products, including Allegra for allergy relief and IcyHot for pain management, making healthcare accessible beyond prescription needs.

  • Vaccines

    Through Sanofi Pasteur, the company is the largest vaccine producer globally, developing and manufacturing vaccines that protect against various infectious diseases, thus playing a pivotal role in global vaccination efforts.

Contact Information

Address: ul. Cisowa 11
Phone: 48 81 444 6480